Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Paraphilic Pathway Down-Regulation In A Specialized Sensitive Group Using taVNS Modulation

NCT05482412 is registered in ClinicalTrials.gov with American University Of Montserrat as lead sponsor.

NCT NCT05482412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05482412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Paraphilic Pathway Down-Regulation In A Specialized Sensitive Group Using taVNS Modulation
Lead sponsor
American University Of Montserrat
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2023
Completion date
December 15, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

desire; sexual, aversion, paraphilia